PGY

SEC source: 0001883085-25-000112 · wk-form4_1750108707.xml · derivative · entry 3

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,375

Underlying: Class A Ordinary Share · 20,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

F2 · derivative.expiration_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

SEC source: 0001883085-25-000112 · wk-form4_1750108707.xml · nonDerivative · entry 2

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,859

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000112 · wk-form4_1750108707.xml · nonDerivative · entry 1

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001883085-25-000111 · wk-form4_1750108670.xml · derivative · entry 3

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,250

Underlying: Class A Ordinary Share · 23,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

F2 · derivative.expiration_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

SEC source: 0001883085-25-000111 · wk-form4_1750108670.xml · nonDerivative · entry 2

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,634

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000111 · wk-form4_1750108670.xml · nonDerivative · entry 1

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001883085-25-000114 · wk-form4_1750120777.xml · derivative · entry 3

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,375

Underlying: Class A Ordinary Share · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

F2 · derivative.expiration_date: The grant vests over a period of two years in eight equal quarterly installments starting on June 12, 2025.

SEC source: 0001883085-25-000114 · wk-form4_1750120777.xml · nonDerivative · entry 2

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,619

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000114 · wk-form4_1750120777.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001883085-25-000110 · wk-form4_1750108628.xml · nonDerivative · entry 1

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,158,694

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.15 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000109 · wk-form4_1750108587.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,115,159

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.15, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000103 · wk-form4_1749673971.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,164,072

F1 · kind: Transfer of shares for no consideration for estate planning purposes from individual holder to a trust of which individual holder is beneficiary and maintains voting and dispositive power. Accordingly, any future transactions in the Issuer's securities by the trust will be subject to Section 16 reporting.

F1 · acquired: Transfer of shares for no consideration for estate planning purposes from individual holder to a trust of which individual holder is beneficiary and maintains voting and dispositive power. Accordingly, any future transactions in the Issuer's securities by the trust will be subject to Section 16 reporting.

SEC source: 0001883085-25-000098 · wk-form4_1749589007.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,181

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $17.29 to $18.07 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000096 · wk-form4_1748988288.xml · nonDerivative · entry 1

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,435

SEC source: 0001883085-25-000094 · wk-form4_1747253265.xml · nonDerivative · entry 1

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,207,675

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.27 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000093 · wk-form4_1747253198.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,380,617

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.27 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000089 · wk-form4_1747172739.xml · nonDerivative · entry 3

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,401,528

F3 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F4 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.25 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000090 · wk-form4_1747172944.xml · nonDerivative · entry 2

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,228,429

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F4 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.26 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000089 · wk-form4_1747172739.xml · nonDerivative · entry 2

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,519,339

F3 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.40 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000089 · wk-form4_1747172739.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.40 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000090 · wk-form4_1747172944.xml · nonDerivative · entry 1

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,346,141

F1 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.40 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000086 · wk-form4_1746821145.xml · nonDerivative · entry 2

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,459

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.76 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000085 · wk-form4_1746821099.xml · nonDerivative · entry 3

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,584,145

F4 · security: Class B Ordinary Shares were converted to Class A Ordinary Shares upon sale.

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.50 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000085 · wk-form4_1746821099.xml · nonDerivative · entry 2

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.50 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000086 · wk-form4_1746821145.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,935

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.76 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000085 · wk-form4_1746821099.xml · nonDerivative · entry 1

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,842

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.80 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000070 · wk-form4_1746475346.xml · nonDerivative · entry 1

Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,712

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.03 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000069 · wk-form4_1746475303.xml · nonDerivative · entry 1

Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,925

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.02 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001883085-25-000063 · wk-form4_1744928336.xml · nonDerivative · entry 2

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,817

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000063 · wk-form4_1744928336.xml · derivative · entry 3

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Class A Ordinary Share · 22,916 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs vest thereafter in 6 equal quarterly installments beginning on July 16, 2024.

F2 · derivative.expiration_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs vest thereafter in 6 equal quarterly installments beginning on July 16, 2024.

SEC source: 0001883085-25-000063 · wk-form4_1744928336.xml · nonDerivative · entry 1

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,606

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001883085-25-000061 · wk-form4_1743711039.xml · nonDerivative · entry 2

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,995

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award.

SEC source: 0001883085-25-000060 · wk-form4_1743710961.xml · nonDerivative · entry 2

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,002

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award.

SEC source: 0001883085-25-000059 · wk-form4_1743710910.xml · nonDerivative · entry 2

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,690

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award.

SEC source: 0001883085-25-000061 · wk-form4_1743711039.xml · derivative · entry 3

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,466

Underlying: Class A Ordinary Share · 28,467 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd vested on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments.

F2 · derivative.expiration_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd vested on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments.

SEC source: 0001883085-25-000061 · wk-form4_1743711039.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,648

SEC source: 0001883085-25-000060 · wk-form4_1743710961.xml · derivative · entry 3

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,360

Underlying: Class A Ordinary Share · 22,772 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/6th of the total 273,224 restricted stock units subject to this award vested each on August 1, 2024, and January 1, 2025, and the remaining 2/3rds of the grant shall vest over the following 24 months in equal quarterly installments. Following the vesting that occurred on April 1, 2025, the remaining vesting schedule is as follows: July 1, 2025, October 1, 2025, January 1, 2026, April 1, 2026, July 1, 2026, October 1, 2026, and January 1, 2027.

F2 · derivative.expiration_date: 1/6th of the total 273,224 restricted stock units subject to this award vested each on August 1, 2024, and January 1, 2025, and the remaining 2/3rds of the grant shall vest over the following 24 months in equal quarterly installments. Following the vesting that occurred on April 1, 2025, the remaining vesting schedule is as follows: July 1, 2025, October 1, 2025, January 1, 2026, April 1, 2026, July 1, 2026, October 1, 2026, and January 1, 2027.

SEC source: 0001883085-25-000060 · wk-form4_1743710961.xml · nonDerivative · entry 1

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,801

SEC source: 0001883085-25-000059 · wk-form4_1743710910.xml · derivative · entry 3

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,614

Underlying: Class A Ordinary Share · 8,538 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th vested on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments.

F2 · derivative.expiration_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th vested on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments.

SEC source: 0001883085-25-000059 · wk-form4_1743710910.xml · nonDerivative · entry 1

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,701

SEC source: 0001883085-25-000055 · wk-form4_1741896591.xml · derivative · entry 1

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Class A Ordinary Share · 190,000 shares

Expires not disclosed

F1 · security: On March 12, 2025, the Reporting Person was granted 190,000 Restricted Stock Units (the "Grant") by the Issuer as part of as part of the company-wide annual grant of equity incentive compensation. The Grant will vest quarterly over 2 years.

F2 · derivative.exercise_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

F2 · derivative.expiration_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

SEC source: 0001883085-25-000054 · wk-form4_1741896521.xml · derivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Class A Ordinary Share · 125,000 shares

Expires not disclosed

F1 · security: On March 12, 2025, the Reporting Person was granted 125,000 Restricted Stock Units (the "Grant") by the Issuer as part of as part of the company-wide annual grant of equity incentive compensation. The Grant will vest quarterly over 2 years.

F2 · derivative.exercise_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

F2 · derivative.expiration_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

SEC source: 0001883085-25-000052 · wk-form4_1741896420.xml · derivative · entry 1

Perros Evangelos · CIK 0002018687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Class A Ordinary Share · 165,000 shares

Expires not disclosed

F1 · security: On March 12, 2025, the Reporting Person was granted 165,000 Restricted Stock Units (the "Grant") by the Issuer as part of as part of the company-wide annual grant of equity incentive compensation. The Grant will vest quarterly over 2 years.

F2 · derivative.exercise_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

F2 · derivative.expiration_date: The grant shall vest over a period of two years in eight equal quarterly installments with an initial vesting date of June 12, 2025.

SEC source: 0001883085-25-000037 · wk-form4_1739484278.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,181

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

SEC source: 0001883085-25-000030 · wk-form4_1738963636.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,550

F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information.

SEC source: 0001883085-25-000026 · wk-form4_1738703251.xml · nonDerivative · entry 2

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,396

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000026 · wk-form4_1738703251.xml · derivative · entry 3

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Share · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4th of the total 125,000 restricted stock units initially subject to this award vested on each of October 31, 2023 and January 31, 2024, and the remaining vests quarterly, in four equal installments.

F2 · derivative.expiration_date: 1/4th of the total 125,000 restricted stock units initially subject to this award vested on each of October 31, 2023 and January 31, 2024, and the remaining vests quarterly, in four equal installments.

SEC source: 0001883085-25-000026 · wk-form4_1738703251.xml · nonDerivative · entry 1

Rosen Tami · CIK 0001970282 · Director · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,175

SEC source: 0001883085-25-000023 · wk-form4_1737495132.xml · nonDerivative · entry 2

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,163

F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award.

SEC source: 0001883085-25-000023 · wk-form4_1737495132.xml · derivative · entry 3

DAS SANJIV · CIK 0001654849 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,748

Underlying: Class A Ordinary Share · 22,917 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs vest thereafter in 6 equal quarterly installments beginning on July 16, 2024.

F2 · derivative.expiration_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs vest thereafter in 6 equal quarterly installments beginning on July 16, 2024.